Search

everythinglearnresearchcommunity

for

Search:↓

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Severe CCCA may be biologically and clinically different from milder forms.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Younger age, longer disease duration, frequent wig use, and lower education levels worsen quality of life in CCCA patients.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

Some natural ingredients like onion juice, rosemary oil, and pumpkin seed oil may help with hair growth and reducing hair loss.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Hair shaft changes may be linked to CCCA, but their role is unclear.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.